(19)
(11) EP 4 770 637 A1

(12)

(43) Date of publication:
08.07.2026 Bulletin 2026/28

(21) Application number: 24880549.1

(22) Date of filing: 17.10.2024
(51) International Patent Classification (IPC): 
A61K 31/395(2006.01)
A61K 31/5585(2006.01)
 A61K 31/505(2006.01)
A61K 31/33(2006.01)
(52) Cooperative Patent Classification (CPC):
A61K 31/7072; A61K 45/06; A61K 31/573; A61K 31/727
 
C-Sets:
  1. A61K 31/7072, A61K 2300/00;
  2. A61K 31/573, A61K 2300/00;
  3. A61K 31/727, A61K 2300/00;
(86) International application number:
PCT/US2024/051708
(87) International publication number:
WO 2025/085591 (24.04.2025 Gazette 2025/17)
(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC ME MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated Extension States:
BA
Designated Validation States:
GE KH MA MD TN

(30) Priority: 17.10.2023 US 202363591068 P

(71) Applicant: JND Therapeutics, Inc.
Wellesley, Massachusetts 02481 (US)

(72) Inventors:
  • DOVE, David
    Wellesley, Massachusetts 02481 (US)
  • REIS, Jonathan
    Wellesley, Massachusetts 02481 (US)

(74) Representative: Vossius & Partner Patentanwälte Rechtsanwälte mbB 
Siebertstraße 3
81675 München
81675 München (DE)

   


(54) LOW DOSING REGIMENS OF FLOXURIDINE AND METHODS OF TREATMENT OF CANCER USING FLOXURIDINE